Exicure, Inc.
(NASDAQ : XCUR)

( )
XCUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -1.23%113.687.9%$608.39m
CHGGChegg, Inc. -2.86%67.9515.3%$188.96m
FLTFleetCor Technologies, Inc. -0.16%233.633.5%$167.52m
CPRTCopart, Inc. -0.30%102.014.4%$151.46m
CDAYCeridian HCM Holding, Inc. -0.34%76.080.0%$134.87m
EFXEquifax, Inc. -0.15%151.942.0%$116.98m
BANDBandwidth, Inc. 0.96%163.160.0%$86.23m
BFAMBright Horizons Family Solutions, Inc. -1.22%140.831.4%$85.98m
STMPStamps.com, Inc. 2.51%236.0024.9%$74.91m
KCKingsoft Cloud Holdings Ltd. -8.11%29.670.0%$69.14m
CRLCharles River Laboratories International, Inc. -0.27%211.974.5%$65.60m
BAHBooz Allen Hamilton Holding Corp. -1.15%82.882.0%$65.52m
PAGSPagSeguro Digital Ltd. 0.22%36.410.0%$62.77m
MEDPMedpace Holdings, Inc. -5.38%106.940.9%$62.28m
BRBroadridge Financial Solutions, Inc. -0.80%127.861.5%$59.27m

Company Profile

Exicure, Inc. is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.